Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

about

Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol

P2860

Q58722819-6BADC56D-2821-4352-9D12-E9CC09116D27

P2860

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

Item

http://www.wikidata.org/entity/Q55425011

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

@en

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

@nl

type

Item

label

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

@en

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

@nl

prefLabel

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

@en

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

@nl

P1476

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

@en

P2093

Oren Tirosh

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1

Hypoxia-inducible factors as molecular targets for liver diseases

Dietary approach in the treatment of nonalcoholic fatty liver disease

Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer

Energy metabolism in the liver

Role of diet on non-alcoholic fatty liver disease: An updated narrative review

The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease

Nonalcoholic fatty liver disease: new treatments

On the Origin of Cancer Cells

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

P304

2548154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1155/2018/2548154

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Oren Tirosh

P5008

ScienceSource

P577

2018-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29955245

http://www.w3.org/2001/XMLSchema#string

P921

hypoxia

lipid

Non-alcoholic fatty liver disease

polycyclic compound

P932

6000860

http://www.w3.org/2001/XMLSchema#string

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

about

P2860

P2860

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P698

P921

P932